EP3558997 - Bibliographic data
COMPOSÉS AMINO-TRIAZOLOPYIDINES ET LEUR UTILISATION POUR TRAITER LE CANCER
| Last update | 03/06/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
AstraZeneca AB 151 85 Södertälje
Suède
|
|---|---|
| (72) Inventors |
Maurice FINLAY AstraZeneca R&D Cambridge
Darwin Building Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0FZ
Royaume-Uni
Frederick GOLDBERG AstraZeneca R&D Cambridge
Darwin Building Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0FZ
Royaume-Uni
Attilla TING AstraZeneca R&D Cambridge
Darwin Building Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0FZ
Royaume-Uni
|
| (74) Agent |
Mail recipient RWS GROUP Europa House - Chiltern Park - Chiltern Hill
SL9 9FG
CHAFLONT ST PETER, Bucks
Royaume-Uni
|
| (21) Request number | EP17825829.9 |
|---|---|
| (22) Request date | 19/12/2017 |
| (11) Publication number | EP3558997 |
|---|---|
| Publication date | 27/01/2021 |
| (54) Title of the invention | COMPOSÉS AMINO-TRIAZOLOPYIDINES ET LEUR UTILISATION POUR TRAITER LE CANCER |
|---|---|
| (51) International classification | C07D 473/18, A61K 31/522, C07D 519/00, A61P 35/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201662436619 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | Annuity: 9 - Amount: 175 € - Due date 31/12/2025 |
|---|---|
| Last annuity | Annuity: 8 - Payment date 28/11/2024 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 27/01/2021 Constitution de mandataire pour un dossier - Legal date 12/04/2021 |